Validation of a monoclonal antibody-based immunofluorescent assay to detect Burkholderia pseudomallei in blood cultures

Trans R Soc Trop Med Hyg. 2016 Nov 1;110(11):670-672. doi: 10.1093/trstmh/trw079.

Abstract

Background: Identification of Burkholderia pseudomallei, the cause of melioidosis, using routine methods takes several days. Use of a monoclonal antibody-based immunofluorescent assay (IFA) on positive blood cultures may speed diagnosis.

Methods: We tested the diagnostic accuracy of the IFA on 545 blood cultures positive for Gram-negative organisms at Udon Thani Hospital, Thailand, between June 2015 and August 2016.

Results: Sensitivity of the IFA was 100% and specificity was 99.6%. The median decrease in time to pathogen identification between the IFA result and routine methods was 28 h (IQR 25-51), p<0.0001.

Conclusions: The IFA accurately expedites the diagnosis of melioidosis.

Keywords: Burkholderia pseudomallei; Bacteremia; Diagnosis; Immunofluorescent assay; Melioidosis; Thailand.

Publication types

  • Validation Study

MeSH terms

  • Blood Culture
  • Burkholderia pseudomallei* / isolation & purification
  • Fluorescent Antibody Technique, Direct
  • Humans
  • Melioidosis* / diagnosis